En Carta Diagnostics

French tech company | Builders Republic

About

Deeptech maker of rapid point-of-care molecular diagnostic kits that helps clinicians detect disease on the spot — a frugal single-use cassette using aptamers to flag pathogens, with early Lyme disease as its first test, designed for fast results outside the lab.

Key facts

Status
Active
Sectors
Healthcare & Life Sciences
Latest stage
Series A
Founded
2022
City
MALAKOFF
Region
IDF
Tracked rounds
2
Amount raised
6.5 M€ raised since 2020

Funding rounds

  • Series A · 2026
  • Seed · 2024

Investors